28.11.2012 Views

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

REFERENCES<br />

Rifat S. L., Eastwood M. R., Crapper McLachlan D. R. and Corey P. N. (1990) Effect <strong>of</strong> exposure<br />

230<br />

<strong>of</strong> m<strong>in</strong>ers to <strong>alum<strong>in</strong>ium</strong> powder. Lancet 336, 1162–1165.<br />

Rippon G. A. and Marder K. S. (2005) Dementia <strong>in</strong> Park<strong>in</strong>son's disease. Adv. Neurol. 96, 95–113.<br />

Roberts E. (1986) Alzheimer’s disease may beg<strong>in</strong> <strong>in</strong> the nose and may be caused by<br />

alum<strong>in</strong>osilicates. Neurobiol. Ag<strong>in</strong>g 7, 561–567.<br />

Rodrigues R. W., Gomide V. C. and Chadi G. (2001) Astroglial and microglial reaction after a<br />

partial nigrostriatal degeneration <strong>in</strong>duced by the striatal <strong>in</strong>jection <strong>of</strong> different doses <strong>of</strong> 6-<br />

hydroxydopam<strong>in</strong>e. Int. J. Neurosci. 109, 91–126.<br />

Rodriguez M. C., Obeso J. A. and Olanow C.W. (1998) Subthalamic nucleusmediated<br />

excitotoxicity <strong>in</strong> Park<strong>in</strong>son’s disease: a target for neuroprotection. Ann. Neurol. 44, S175–<br />

188.<br />

Rodríguez-Díaz M., Abdala P., Barroso-Ch<strong>in</strong>ea P., Obeso J. and González-Hernández T. (2001)<br />

Motor behavioural changes after <strong>in</strong>tracerebroventricular <strong>in</strong>jection <strong>of</strong> 6-hydroxydopam<strong>in</strong>e<br />

<strong>in</strong> the rat: an animal model <strong>of</strong> Park<strong>in</strong>son's disease. Behav. Bra<strong>in</strong> Res. 122, 79–92.<br />

Rodriguez M., Barroso-Ch<strong>in</strong>ea P., Abdala P., Obeso J. and Gonzalez-Hernandez T. (2001)<br />

Dopam<strong>in</strong>e cell degeneration <strong>in</strong>duced by <strong>in</strong>traventricular adm<strong>in</strong>istration <strong>of</strong> 6-<br />

hydroxydopam<strong>in</strong>e <strong>in</strong> the rat: similarities with cell loss <strong>in</strong> Park<strong>in</strong>son’s disease. Exp. Neurol.<br />

169, 163–181.<br />

Rodriguez-Pallares J., Parga J. A., Muñoz A., Rey P., Guerra M. J., Labandeira-Garcia J. L. (2007)<br />

Mechanism <strong>of</strong> 6-hydroxydopam<strong>in</strong>e <strong>neurotoxicity</strong>: the role <strong>of</strong> NADPH oxidase and microglial<br />

activation <strong>in</strong> 6-hydroxydopam<strong>in</strong>e-<strong>in</strong>duced degeneration <strong>of</strong> dopam<strong>in</strong>ergic neurons. J.<br />

Neurochem. 103, 145–156.<br />

Roedter A., W<strong>in</strong>kler C., Samii M., Walter G. F., Brandis A. and Nikkhah G. Comparison <strong>of</strong><br />

unilateral and bilateral <strong>in</strong>trastriatal 6-hydroxydopam<strong>in</strong>e-<strong>in</strong>duced axon term<strong>in</strong>al lesions:<br />

evidence for <strong>in</strong>terhemispheric functional coupl<strong>in</strong>g <strong>of</strong> the two nigrostriatal pathways. J.<br />

Comp. Neurol. 432, 217–229.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!